Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03).
- Citation:
- J Clin Oncol vol 40 (5) 449-58
- Year:
- 2022
- Type:
- Manuscript
- Funding:
- AFT
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 11
- Parents:
- 3470
- Children:
- None
- Pharmas:
- Pfizer
- Grants:
- Corr. Author:
- Authors:
- Erica L Mayer Christian Fesl Dominik Hlauschek Laura Garcia-Estevez Harold J Burstein Nicholas Zdenkowski Viktor Wette Kathy D Miller Marija Balic Ingrid A Mayer David Cameron Eric P Winer José Juan Ponce Lorenzo Diana Lake Gunda Pristauz-Telsnigg Tufia C Haddad Lois Shepherd Hiroji Iwata Matthew Goetz Fatima Cardoso Tiffany A Traina Dhanusha Sabanathan Urs Breitenstein Kerstin Ackerl Otto Metzger Filho Karin Zehetner Kadine Solomon Sarra El-Abed Kathy Puyana Theall Dongrui Ray Lu Amylou Dueck Michael Gnant Angela DeMichele
- Networks:
- LAPS-CT018, LAPS-MA036, LAPS-MN026, LAPS-NY016, LAPS-PA015, LAPS-TN008
- Study
- AFT-05
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: